These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 24481905)
1. Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs. de Almeida Leandro L; Fraga CM; de Souza Lino R; Vinaud MC Parasitol Res; 2014 Apr; 113(4):1313-7. PubMed ID: 24481905 [TBL] [Abstract][Full Text] [Related]
2. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies. Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532 [TBL] [Abstract][Full Text] [Related]
3. Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci. Lima NF; Picanço GA; Alves DSMM; Silva LD; Isac E; Costa TL; Lino Junior RS; Vinaud MC Acta Trop; 2019 Feb; 190():361-364. PubMed ID: 30553893 [TBL] [Abstract][Full Text] [Related]
4. Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis. Correia LTB; de Lima NF; Gomes TC; De Sousa Guerra CH; Costa TL; Vinaud MC Acta Trop; 2022 Oct; 234():106571. PubMed ID: 35752205 [TBL] [Abstract][Full Text] [Related]
5. Elucidating the influence of praziquantel nanosuspensions on the in vivo metabolism of Taenia crassiceps cysticerci. Silva LD; Arrúa EC; Pereira DA; Fraga CM; Costa TL; Hemphill A; Salomon CJ; Vinaud MC Acta Trop; 2016 Sep; 161():100-5. PubMed ID: 27269203 [TBL] [Abstract][Full Text] [Related]
6. Taenia crassiceps: host treatment alters glycolisis and tricarboxilic acid cycle in cysticerci. Fraga CM; Costa TL; Bezerra JC; de Souza Lino R; Vinaud MC Exp Parasitol; 2012 Feb; 130(2):146-51. PubMed ID: 22127328 [TBL] [Abstract][Full Text] [Related]
7. Fatty acids oxidation and alternative energy sources detected in Taenia crassiceps cysticerci after host treatment with antihelminthic drugs. Fraga CM; Costa TL; Bezerra JC; de Souza Lino Junior R; Vinaud MC Exp Parasitol; 2012 May; 131(1):111-5. PubMed ID: 22465501 [TBL] [Abstract][Full Text] [Related]
8. Albendazole - Ivermectin combination decreases inflammation in experimental neurocysticercosis. da Silva Santana RC; Prudente TP; de Sousa Guerra CH; de Lima NF; de Souza Lino Junior R; Vinaud MC Exp Parasitol; 2023 Aug; 251():108568. PubMed ID: 37327965 [TBL] [Abstract][Full Text] [Related]
9. In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions-a metabolic approach. Silva LD; Lima NF; Arrua EC; Salomon CJ; Vinaud MC Drug Deliv Transl Res; 2018 Oct; 8(5):1265-1273. PubMed ID: 30117119 [TBL] [Abstract][Full Text] [Related]
10. Histopathologic evaluation of experimental murine neurocysticercosis after treatment with albendazole/nitazoxanide combination. Sampaio GA; Zago LV; de Lima NF; Picanço GA; Lino Júnior RS; Vinaud MC Parasitology; 2020 Jun; 147(7):822-827. PubMed ID: 32234089 [TBL] [Abstract][Full Text] [Related]
11. Partial inhibition of the main energetic pathways and its metabolic consequences after Picanço GA; de Lima NF; Gomes TC; Fraga CM; Alves DSMM; Castillo R; da Costa TL; Lino-Junior RS; Ambrosio J; Vinaud MC Parasitology; 2019 Oct; 146(12):1578-1582. PubMed ID: 31303189 [TBL] [Abstract][Full Text] [Related]
12. Partial inhibition of the tricarboxylic acid cycle in Taenia crassiceps cysticerci after the in vitro exposure to a benzimidazole derivative (RCB15). Picanço GA; Lima NF; Alves DS; Fraga CM; Costa TL; Junior RSL; Castillo R; Hernández-Campos A; Ambrosio J; Vinaud MC Acta Trop; 2020 Feb; 202():105254. PubMed ID: 31689380 [TBL] [Abstract][Full Text] [Related]
13. Experimental encephalitis caused by Taenia crassiceps cysticerci in mice. Matos-Silva H; Reciputti BP; Paula EC; Oliveira AL; Moura VB; Vinaud MC; Oliveira MA; Lino-Júnior Rde S Arq Neuropsiquiatr; 2012 Apr; 70(4):287-92. PubMed ID: 22358311 [TBL] [Abstract][Full Text] [Related]
14. In vitro nitazoxanide exposure affects energetic metabolism of Taenia crassiceps. Isac E; Picanço GA; Costa TL; Lima NF; Alves DSMM; Fraga CM; Lino Junior RS; Vinaud MC Exp Parasitol; 2020 Jan; 208():107792. PubMed ID: 31707003 [TBL] [Abstract][Full Text] [Related]
15. Taenia crassiceps: energetic and respiratory metabolism from cysticerci exposed to praziquantel and albendazole in vitro. Vinaud MC; Ferreira CS; Lino Junior Rde S; Bezerra JC Exp Parasitol; 2008 Nov; 120(3):221-6. PubMed ID: 18694746 [TBL] [Abstract][Full Text] [Related]
16. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel. Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213 [TBL] [Abstract][Full Text] [Related]
17. In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis. Nasareth JM; Fraga CM; Lima NF; Picanço GA; Costa TL; Lino-Junior RS; Vinaud MC Parasitol Res; 2017 Nov; 116(11):3037-3041. PubMed ID: 28914356 [TBL] [Abstract][Full Text] [Related]
18. Oxfendazole Nitazoxanide combination in experimental neurocysticercosis - Anti-inflammatory and cysticidal effects. Araújo JAA; Gomes TC; Lima VCN; Silva YBD; Lino Junior RS; Vinaud MC Exp Parasitol; 2024 Jul; 262():108764. PubMed ID: 38677580 [TBL] [Abstract][Full Text] [Related]
19. In vivo albendazole treatment of Taenia crassiceps cysticerci strain WFU: proliferation, damage, and recovery. Zurabian R; Aguilar-Vega L; Terrones Vargas E; Cervera Hernández ME; Willms K; Ruíz-Velasco Acosta S Parasitol Res; 2013 Nov; 112(11):3961-8. PubMed ID: 24005476 [TBL] [Abstract][Full Text] [Related]